D3Targets-2019-nCoV: a webserver for predicting drug targets and for multi-target and multi-site based virtual screening against COVID-19-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

D3Targets-2019-nCoV: a webserver for predicting drug targets and for multi-target and multi-site based virtual screening against COVID-19

Published:2020-07 Issue:7 Volume:10 Page:1239-1248
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Shi Yulong,Zhang Xinben,Mu Kaijie,Peng Cheng,Zhu Zhengdan,Wang Xiaoyu,Yang Yanqing,Xu Zhijian,Zhu Weiliang

Funder

National Key Research and Development Program of China

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference44 articles.

1. A novel coronavirus from patients with pneumonia in China, 2019;Zhu;N Engl J Med,2020

2. A pneumonia outbreak associated with a new coronavirus of probable bat origin;Zhou;Nature,2020

3. A new coronavirus associated with human respiratory disease in China;Wu;Nature,2020

4. First case of 2019 novel coronavirus in the United States;Holshue;N Engl J Med,2020

5. Potential inhibitors for 2019-nCoV coronavirus M protease from clinically approved medicines;Liu;J Genet Genomics,2020

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protective effect and mechanism of Qingfei Paidu decoction on myocardial damage mediated by influenza viruses;Frontiers in Pharmacology;2024-02-27

2. Role of artificial intelligence in cancer diagnostics and therapeutics;Biomarkers in Cancer Detection and Monitoring of Therapeutics;2024

3. CHARACTERIZATION AND MOLECULAR DOCKING OF CINNAMIC ACID DERIVATIVES: POTENTIAL INHIBITORS OF CYCLOOXYGENASE ENZYMES;Innovare Journal of Life Sciences;2023-10-27

4. D3CARP: a comprehensive platform with multiple-conformation based docking, ligand similarity search and deep learning approaches for target prediction and virtual screening;Computers in Biology and Medicine;2023-09

5. The Coming of Age of AI/ML in Drug Discovery, Development, Clinical Testing, and Manufacturing: The FDA Perspectives;Drug Design, Development and Therapy;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3